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Abstract
The pathology of Type I Diabetes mellitus is characterized by a significant or 
complete ablation of the insulin secreting p-cell population of the pancreas. The 
loss of P-cell mass is mediated by apoptosis and it has been shown that the 
enzyme caspase-3 plays a pivotal role in the execution of apoptosis. Imaging of 
caspase-3 in live p-cells can provide a novel tool for exploring disease 
progression in Type 1 diabetes. In this thesis I have validated the use of a 
bioluminescent caspase-3 reporter for monitoring apoptosis induced by pro- 
inflammatory cytokines in a clonal rat derived P-cell line (INS-1/832/13). I have 
shown that the caspase-3 reporter construct and imaging strategy can detect 
changes in caspase-3 activity with high sensitivity and temporal resolution, and 
that caspase-3 activity induced by cytokines is transient in nature.
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1 Introduction
Blood glucose levels are maintained by the pancreatic hormones insulin and 
glucagon. Diabetes Mellitus is a chronic disease in which ability to regulate blood 
glucose homeostasis is lost. The disease state in diabetes is characterized by an 
absolute or relative deficiency in insulin secretion.
1.1 Pathology of Diabetes
There are predominantly two types of diabetes, Type 1 diabetes mellitus (T1DM) 
and Type 2 diabetes mellitus (T2DM). Pathogenesis of T1DM and T2DM follows 
different mechanisms, but ultimately they both result in a significant or complete 
ablation of the insulin secreting beta-cell (P-cell) population. In the development 
of T2DM, environmental factors play a strong role in individuals that are 
genetically predisposed. The mechanism for T2DM pathology involves an 
increase in insulin resistance of peripheral tissues that triggers more insulin 
secretion from the pancreatic p-cells in order to compensate for aberrant insulin 
responses peripherally. The constantly elevated secretion levels of insulin lead to 
increased stress on the endoplasmic reticulum (ER) and mitochondria of the p- 
cell, eventually resulting in P-cell failure and death by apoptosis1.
T1DM is an autoimmune condition in which an immune attack is launched 
against the P-cells. Histological sections of rodent and human islets from affected 
individuals show an infiltration of CD4+ T-helper cells, CD8+ cytotoxic T-cells, 
macrophages and natural killer cells into the islet, a phenomenon called insulitis. 
Within this lesion of insulitis a number of cytokines have been identified, the most
2
important of which are the pro-inflammatory cytokines: Tumor Necrosis 
Factor(TNF)-a , Interferon (IFN)-y and Interleukin (IL)-1|3. Treatment of rat 
insulinoma derived INS-1 cells, mouse derived NIT cells and primary islet 
cultures with this combination of cytokines has been found to cause cell death by 
apoptosis2'5. IL-1 (3 has been found to be the primary mediator of P-cell 
dysfunction by selectively inhibiting insulin secretion6 and upregulating the 
expression of Fas (CD95)7 The upregulation of Fas makes the cell more 
susceptible to death receptor mediated apoptosis. IFN-y has not been found to 
be toxic on its own. However, in combination with IL-1 (3 and/or TNF-a, IFN-y has 
been shown to have profound effects on [3-cell biology and function2, 5. 
Furthermore, IFN-y has been shown to potentiate the effects of IL-1 (3 through the 
suppression of ER stress defence mechanisms2,8, and increase susceptibility to 
TNF-a induced apoptosis9 by inhibition of NF-kB mediated anti-apoptotic 
pathways. In combination all three cytokines cause significant toxicity.
1.1.1 Beta-cell Apoptosis
Apoptosis plays a pivotal role in the development of both variants of 
diabetes. It appears to be the primary mechanism of cell death involved in the 
loss of (3-cell mass. Apoptosis is a form of programmed cell death that occurs 
throughout development and life. It is a highly conserved ATP-dependent 
process by which a cell is systematically dismantled. The morphological 
hallmarks of apoptosis include decreased cell size, abnormal cell shape and 
nuclear fragmentation. Prior to the morphological transformation of the cell, a
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very specific set of biochemical changes occur. The process leading to apoptosis 
involves 2 major pathways: an extrinsic pathway and an intrinsic pathway 
illustrated in Figure 1-1.
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Figure 1-1: Schematic of apoptotic pathways showing that both extrinsic and intrinsic pathways 
converge on the activation of caspase-3 that eventually leads to cell destruction. The extrinsic 
pathway can be initiated by members of the tumor necrosis factor family and activates caspase-3 
directly through the activation of caspase-8. The extrinsic pathway can indirectly activate the 
intrinsic pathway by the truncation of Bid, leading to caspase-3 activation by both caspase-8 and 
caspase-9. The intrinsic pathway is initiated by the proinflammatory cytokines IFN-y and IL-1 ß. In 
the intrinsic pathway caspase-3 is activated following dephosphorylation of the pro-apoptotic Bcl- 
2 protein BAD. BAD dephosphorylation enables the release of mitochondrial proteins into the 
cytosol that cause the activation of caspase-9 and eventually caspase-3. When caspase-3 is 
cleaved it can cleave a number of substrates including PARP and eventually lead to cell death.
Induction of both the intrinsic and extrinsic pathways causes the activation of a 
family of proteolytic enzymes called caspases. The name caspase is derived
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from the words Cysteine ASPartic acid ProteASE. To date 14 mammalian 
caspases have been discovered, and have been classified as initiator and 
executioner caspases. The initiator caspases are characterized by the presence 
of a larger regulatory domain which is involved in protein-protein interactions with 
adaptor proteins and receptors10. A feature that is conserved between all 
caspases is the presence of a large and small subunit. X-ray crystallography of 
caspase-1 and caspase-3 showed that the active form of both enzymes requires 
the formation of a heterodimer between large and small subunits; and the 
heterodimers in turn form tetramers to become catalytically active11"13. Caspase-3 
has been found to be central in the execution of apoptosis in many cell types.
1.1.2 Caspase-3 in Type 1 Diabetes Mellitus
Caspase-3 is classified as an executioner caspase and has a number of 
substrates. Caspase-3 preferentially cleaves at the amino acid sequence 
[DEVD|G], a sequence that was discovered to be a part of Poly ADP Ribose 
Polymerase (PARP)10. The normal role of PARP is to repair DNA damage. Its 
role in apoptosis, or more specifically, the importance of its cleavage by caspase- 
3 is not clear. Boulares A.H et al14 have demonstrated that expression of a 
caspase-3 resistant PARP or over expression of PARP advances apoptosis 
much faster than in wild type cells14. The mechanism behind this acceleration 
has not been thoroughly studied and may have interesting implications for 
apoptosis drug design and therapies. Nevertheless, in the context of diabetes, 
caspase-3 has been shown to play a critical role in (3-cell apoptosis, and appears
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to be a central mediator of T1DM pathology. Laidis et al15 have demonstrated the 
importance of caspase-3-dependent apoptosis in the initiation of T1DM through a 
genetic approach. Specifically, caspase-3'/_ and caspase-3+/+ mice were treated 
with streptozotocin (STZ) to induce diabetes. The caspase-3/_ mice did not 
develop diabetes, and there was no evidence of insulitis in their pancreata. Bone 
marrow transplants from caspase-3+/+ mice did not cause insulitis in caspase-3_/' 
mice suggesting that caspase-3 deficiency in immune cells was not responsible 
for the lack of insulitis15. These results demonstrate the importance of caspase-3 
in priming the immune system with (3-cell antigens.
The importance of caspase-3 has also been demonstrated in islet transplantation 
protocols. It has been shown that treatment with the caspase-3 inhibitor Z-DEVD- 
FMK immediately after islet isolation increased islet survival in a dose dependent 
manner16. These islets also survived longer and resulted in prolonged glycémie 
control over a 30 day period16. Another group demonstrated that administration of 
pan caspase inhibitor Z-VAD-FMK to STZ treated mice for 5 days after 
transplantation preserved islet function for as long as a year in comparison to 
controls17. All in all the role of caspase-3 is extremely important in the 
development of T1DM and determining islet survival. Monitoring caspase-3 in 
living cells before the development of diabetes could provide more insight into 
the pathology of T 1 DM.
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1.1.3 Glucagon Like Peptide-1 & (3-cell apoptosis
A number of paracrine and endocrine factors contribute to (3-cell function and
survival. Among the endocrine factors is a hormone called Glucagon Like 
Peptide (GLP)-1. GLP-1 is a 31 amino acid peptide produced in the L-cells of the 
distal ileum. GLP-1 is derived from the post translational cleavage of 
proglucagon, and is one of a number of potential products of proglucagon. 
Processing of proglucagon into GLP-1 is mediated by the prohormone 
convertase (PC) 1/3 in endocrine cells18.
The primary trigger for GLP-1 secretion is the ingestion of food rich in 
carbohydrates and fatty acids. GLP-1 is best known for inducing gluclose 
dependent insulin secretion, while inhibiting glucagon secretion (incretin effect). It 
has also been shown to play a role in (3-cell survival. Sherry et al19 and Yang et 
al20 have demonstrated that in combination with immunomodulation, GLP-1 
agonist exendin-4 was capable of reversing T1 DM in non obese diabetic (NOD) 
mice19,20. Similarly expression of a GLP-1/lgG-Fc fusion protein has been shown 
to protect against STZ induced (3-cell death and enhances (3-cell mass in diabetic 
CD1 mice21. Wideman R. et al22 further demonstrated the positive effects that 
endogenous GLP-1 expression has on islet function and survival, showing that 
endogenous GLP-1 in islets improves insulin secretion, improves graft survival 
and also protects the islets against IL-1 (3 induced toxicity22. In all three studies 13- 
cell mass was shown to be enhanced after treatment with GLP-1/exendin-4 and 
the p-cells were protected against injury. The mechanisms behind the positive
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effects on [3-cell survival have revealed a pleiotropic nature to enhancement of |3- 
cell survival. Buteau et al have demonstrated that GLP-1 activates Phosphotidyl 
lnositol-3 Kinase (PI3-K), increases DNA synthesis and pancreatic and duodenal 
homeobox (PDX)-1 binding to DNA23. Similarly, Wang Q. et al24 has found that 
GLP-1 regulates proliferation and apoptosis through the activation of Protein 
Kinase B, a substrate of PI3-K. Treatment of INS-1 cells with GLP-1 significantly 
increases cell survival when apoptosis is induced with staurosporine (STS), a 
potent activator of apoptosis24. This effect is prevented by PI-3K inhibitor 
wortmannin24. Activation of the PI3-K pathway is essential for the survival and 
anti apoptotic effects of GLP-1, and has been found to occur through the trans­
activation of the Epidermal Growth Factor receptor by the GLP-1 receptor25. The 
more specific effects of GLP-1 on apoptosis have been elucidated by Li et al26. In 
his study it was shown that P-cells treated with exendin-4, a GLP-1 receptor 
agonist, were protected against cytokine induced apoptosis and that GLP-1 
inhibits the release of cytochrome c into the cytosol after (3-cell injury26. The 
release of cytochrome c is a critical step in the induction of intrinsic apoptosis 
and caspase-3 activation. Li and colleagues26 further demonstrated a marked 
decrease in the relative activities of caspase-8, caspase-9 as well as caspase- 
326. Further solidifying the pleiotropic nature of GLP-1 action on apoptosis, Hui et 
al27 have shown that GLP-1 inhibits apoptosis in a cyclic AMP (cAMP) dependent 
Protein Kinase A and PI3-K dependent manner27. Co-treatment of the mouse 
insulinoma derived MIN6 cells with GLP-1, and either PI3-K inhibitor LY294002
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or cAMP inhibitor Rp-cAMP, did not protect MIN6 cells from hydrogen peroxide 
induced cell death, whereas co-treatment with GLP-1 and MAPK inhibitor 
PD098059 protected the cells from apoptosis27. The results of these studies 
demonstrate that the inhibition of caspase-3 activity by GLP-1 works through 
both the intrinsic and extrinsic pathways.
1.2 Molecular Imaging of Apoptosis
In recent years imaging of P-cell mass has been an area of extensive research 
because it can provide a non invasive method of quantifying p-cell mass and it 
has the potential to detect changes in that mass before any symptoms become 
apparent. There are two dominant strategies in molecular imaging, 1) using 
exogenous contrast and 2) using endogenous contrast. Exogenous contrast 
involves the introduction of a targeted contrast agent (probe) that can recognize 
a molecule of interest, while endogenous contrast can be genetically encoded to 
mirror the molecule of interest in expression or action (reporter). Each of these 
methods has strengths and limitations. The greatest strength of a probe is that it 
can be modified to work with multiple imaging modalities with more ease than a 
reporter can be, and it is more applicable to in vivo imaging. The greatest 
limitation of both targeted probes and intracellular reporters is that of clearance. If 
a probe is not efficiently cleared, or the clearance organs are in close proximity to 
the organ of interest, high background significantly degrades contrast to 
background ratio. Because intracellular reporters are genetically encoded, they 
are generally limited by the strength and specificity of their promoters, or the
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efficiency of the process they are responding to. The greatest strengths of a well- 
designed reporter are the levels of tissue and cell specificity, and the ability to 
report dynamic processes such as gene expression and enzyme activity.
In this laboratory, studies involving imaging of the GLP-1 receptor have 
generated a number of targeted probes for in vivo imaging28. The present thesis 
deals specifically with imaging the more dynamic processes that precede 
changes in (3-cell mass and monitoring apoptosis in an in vitro system. The 
complexity of apoptosis allows for a great number of imaging targets and events. 
There have been a number of probes designed with the purpose of imaging 
apoptosis. This section will outline some of the imaging targets that these probes 
have been generated against and highlight some of the probes.
To date the most successful imaging probes have been Annexin V (A5) based 
probes that are sensitive to late stages of apoptosis. The membrane lipids 
phosphatidylserine (PS) and phosphatidylethanolamine (PE) are normally 
expressed on the interior leaflet of the plasma membrane (PM). Towards the end 
of apoptosis the inner and outer leaflets of the PM are rearranged, resulting in 
the exposure of inner leaflet lipids (PS and PE) to the extra cellular matrix. 
Annexin V labeled probes target PS and have been used extensively in flow 
cytometry to detect apoptosis in cell populations. In 2005 a fluorescence probe 
based on A5 labelling was generated for the imaging of apoptosis in diabetes 
and was shown to successfully localize to apoptotic cells in mouse pancreata29. 
Despite their success in imaging the pancreas, PM scrambling represents end
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stage apoptosis. This also provides very little information regarding cellular 
function and limited temporal resolution for the internal events in the cell. Another 
probe that takes advantage of the rearranging of the PM is a positron emission 
tomography (PET) based probe, 18F-labeled-5-fluoropentyl-2-methyl-malonic acid 
([18F] ML-10). [F18] ML-10 is an amphipathic small molecule that selectively enters 
apoptotic cells after the PM is rearranged. A study published in 2008 evaluated the 
performance of this probe as a PET reporter in an experimental cerebral stroke model 
and successfully detected apoptosis in rat brains30. The limitations of this probe are 
similar to those of A5 labeled probes in that they take advantage of more or less static 
aspects of a dynamic process. As a result of these limitations, novel designs for 
imaging probes and more complex and dynamic targets are required.
Imaging probes that detect earlier points in apoptosis include several small molecules for 
Positron Emission Tomography (PET) and optical imaging. Intracellular, genetically 
encoded reporters are better suited for capturing the dynamic nature of apoptosis 
than extracellular, targeted probes. Changes in mitochondrial permeability 
directly precede activation of the intrinsic caspase cascade and can be measured 
in multiple ways. With the exception of cellular electrophysiology, the standards 
for measuring changes in mitochondrial permeability are fluorescent 
mitochondrial dyes that include JC-1, CMXRos and DiOCe(3).
JC-1 (5,5’, 6,6’-tetrachloro-1,1,3,3’-tetraethylbenzimidazolylcarbocyanine iodide) 
is a carbocyanine mitochondrial dye that reversibly transitions between green 
and red fluorescence in a concentration dependent manner. The dye localizes to
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the intermembrane space of the mitochondria and forms what are known as J- 
aggregates at high concentrations. These J-aggregates fluoresce red with 
emission at 590 nm, and upon mitochondrial membrane permeabilization, the 
dye moves down its concentration gradient resulting in the dissociation of the J- 
aggregates and a transition to green fluorescence at 527 nm31. When compared 
with DiOC6(3) and CMXRos, JC-1 is the only dye capable of detecting changes in 
mitochondrial permeability, while all are capable of discerning cell viability32. JC-1 
has been used extensively in flow cytometry, and has also been used to measure 
changes in mitochondrial potential in individual mitochondria33. The Leow et al33 
approach provides in situ measurement of mitochondrial potential, but requires a 
complicated set up and highly sensitive instruments. As a result, a more general 
method that takes advantage of the power of ratiometric normalization was 
developed34, and this method has been adapted for use in INS-1 cells35.
Isatins are a class of small molecules that are competitive and reversible 
inhibitors of caspase-3. To date, 3 isatin based probes have been generated with 
varying success. Recently D.L Chen et al36 published a comparative study of the 
efficiency of [ 11C] WC-98 and [18F] WC-IV-3 in detecting caspase-3 activity with 
PET imaging36. In brief, Sprague Dawley rats were injected intravenously with 
cyclohexamide, an inhibitor of protein synthesis and inducer of apoptosis, 3 h 
before administration of the tracers. Micro PET images were taken using a 60 
min dynamic scan. The imaging data showed that rats receiving [18F]WC-IV-3 
accumulated the probe in the liver more so than those receiving [11C]WC-98.
12
Biodistribution data showed significant accumulation of [18F]WC-IV-3 in several 
tissues within 30 min and only in the liver after 60 min. In contrast, accumulation 
of [11C]WC-98 in the liver was observed within 30 min36. This study does not 
effectively demonstrate the efficacy of using isatin based probes for detecting 
caspase-3 activity in vivo because they were not targeted to a specific tissue. 
Accumulation in the liver is likely due to clearance of the probe, not apoptosis. 
The PET based isatin probes described in this section may very well be excellent 
probes in vivo. However, the comparative study in question did not effectively 
show the probes ability to localize to apoptotic cells. Improving the experimental 
design would more effectively test the true performance of the isatin based 
probes. In order to better test their performance as detectors apoptosis, injection 
of the isatin probes should follow the induction of apoptosis in a tissue that is 
distant from the clearance organs. This would ensure that increases in probe 
accumulation are in fact due to apoptosis and not clearance.
13





















1.2.1 Genetically Encoded Caspase-3 Reporters
The probes in Table 1, with the exception of the mitochondrial permeability 
probes, are excellent for animal work because they can be injected and they 
achieve good tissue penetration. All probes are subject to the same problems 
when imaging the pancreas. Given the size of the pancreas and its proximity to 
the liver and kidneys, the major clearance organs, isolating a specific signal that 
can be resolved from the high background in the clearance organs is a major 
challenge. In preclinical research, another way these issues can be resolved is to 
use genetically encoded reporters. The advantage to using genetically encoded 
reporters is that they can be targeted not only to a specific process, but also to a 
specific cell type. Many genetically encoded reporters for apoptosis have now 
been generated, including caspase-3 sensors designed for optical imaging
14
(fluorescence, Forster Resonance Energy Transfer (FRET), and 
bioluminescence).
1.2.2 Principles of Optical Imaging & Optical contrast agents
Optical imaging relies on the detection of photons that lie within the visual range
of the electromagnetic spectrum. These wavelengths range from 390 nm to 750 
nm and correspond to blue and red light respectively. There are several detection 
and image capture strategies in place for optical imaging. Microscopy is the most 
commonly used optical technique and it is primarily used to capture 
ultrastructural information at a subcellular level. With the use of novel fluorescent 
probes and reporters, microscopy is also used for functional imaging at a cellular 
level. Fluorescence is a molecular property that results in the emission of 
photons after the absorption of energy. At a more fundamental level, 
fluorescence occurs when an orbital electron of an atom (fluorophore) absorbs 
energy from a photon and rises to an excited energy state. When this electron 
returns to its ground state energy, it emits a photon at a wavelength longer (lower 
energy) than the one it absorbed. The amount of energy that can be absorbed by 
the electron is discrete, and as a result, when the electron returns to ground state 
the photon emitted will have a discrete and specific energy or wavelength. 
Different fluorophores have specific emission spectra making them useful for 
examining several different subcellular structures or processes simultaneously.
Bioluminescence is an optical property that results in the emission of photons 
from a chemical reaction. This reaction is mediated by enzymes called
15
luciferases that catalyze the metabolism of their substrates. In molecular biology, 
two luciferases, (Sea pansy) Renilla reniformis luciferase (RLuc) and (firefly) 
Photuris lucicrescens luciferase (Flue) are commonly used. Rluc is a 35 kDa 
single chain polypeptide that metabolizes luciferin and has an emission spectrum 
peak at 480 nm37. Rluc is not typically used on its own in in vivo imaging 
because of the propensity of biological tissues to absorb light in the Rluc 
emission spectrum. In biological systems Rluc is typically coupled with a 
fluorophore that has an emission spectrum better suited for tissue penetration in 
a form of resonance energy transfer. Firefly luciferase is a 62 kDa single chain 
polypeptide with an emission peak at 560 nm and a quantum yield of 0.88, the 
highest of all known luciferases. Crystallography of Flue reveals that Flue folds 
into two distinct domains, a large N terminal domain and a small C terminal 
domain that are separated by a wide, flexible cleft38. The active site of the 
enzyme is formed by the N terminus and C terminus sandwiching the substrates, 
and creating a favorable environment for the light reaction to occur38. The light 
reaction of luciferase requires ATP and molecular oxygen. D-luciferin and ATP 
enter the active site of luciferase and form a high energy intermediate. Oxygen is 
then incorporated into the substrate, and the energy from the intermediate is 
released as a photon. The resulting products are oxyluciferin and a photon 




+ Photons + C02 + H20
Figure 1-2: Schematic of Firefly Luciferase light reaction. D-Luciferin in the presence of 
Luciferase ATP and Oxygen is metabolized into Oxyluciferin by a two step process that results in 
the emission of photons, C 02, inorganic phosphates, AMP and H20.
1.2.3 Fluorescence and Forster Resonance Energy Transfer based 
Caspase-3 Reporters
Fluorescence reporters, such as the Green, Red and Yellow Fluorescent proteins 
(GFP, RFP & YFP) have been used extensively for imaging. In recent studies, a 
strategy for detecting caspase-3 activity with fluorescence, outside of 
multimodality reporters, has relied on the localization of the fluorophore to detect 
activation. In 2008 the reporter Apoliner was generated and characterized by 
Bardet P.L et al39. The approach of this study involved a combination of 
enhanced GFP and mRFP that were linked to a nuclear localization signal (NLS) 
and a transmembrane protein fragment respectively. The two chimeric proteins
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were then linked by a caspase cleavage site. In the event of caspase-3 
activation, the reporter would be cleaved, releasing eGFP-NLS and allowing that 
protein to accumulate in the nucleus. This reporter was shown to successfully 
respond to caspase-3 activation in living dMP2 embryonic neurons and in the 
epidermis of developing Drosophila embryos in a time dependent manner, 
achieving temporal resolution on the order of minutes39. While this reporter is 
promising, the cleavage of the reporter is not reversible; also, like all fluorescent 
probes, it is susceptible to auto fluorescence. A similar reporter that takes 
advantage of a NLS was published in 2007 by Golbs et al40. This reporter, like 
Apoliner has the strength of high spatial and temporal resolution, but is subject to 
the same limitations.
Förster resonance energy transfer (FRET) is a phenomenon that was initially 
described by Förster in 1948 where energy is transferred from a donor 
fluorophore to a recipient fluorophore in a non radiative manner. This 
phenomenon occurs at a critical proximity of the fluorophores to each other, 
known as the Förster distance. Upon energy transfer, the donor returns to its 
ground state, and the recipient absorbs the energy in discrete packets, and 
returns to its ground state by emitting a photon. Since FRET depends on 
fluorophore proximity, it is an excellent tool with which to report protein-protein 
interactions, and has been used more recently in protease reporter design. In 
1998 X. Xu et al41 described a caspase-3 FRET reporter containing eGFP and 
enhanced Blue Fluorescent Protein (eBFP). It was hypothesized that linking
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these two proteins with a short peptide sequence containing the DEVD sequence 
would result in a FRET signal from eGFP that would be abrogated by the 
cleavage of that sequence by caspase-3. Reporter activity in response to 
caspase-3 was detected through Fluorescence Activated Cell Sorting (FACS), a 
form of flow cytometry41. This report demonstrated a proof of principle, and 
several variations on this reporter have since been generated. Most notably the 
same group made a reporter capable of simultaneously detecting caspase-3 and 
caspase-6 activity42 and Bioluminescence Resonance Energy Transfer (BRET) 
reporters43. The BRET reporters work by using Renilla luciferase as the energy 
donor and GFP and YFP as recipients with slight differences in spectral emission 
and BRET efficiencies44. A great advantage of this method is that it is more 
sensitive than FRET and eliminates the need for an exciting laser to induce 
fluorescence. The increase in sensitivity results from the absence of tissue 
autofluorescence.
1.2.4 Firefly Luciferase Caspase-3 Reporters
To date there are 5 FLuc based caspase-3 reporters. At the time this work began 
there were 4, each employing different methods of quenching FLuc activity. The 
first generation was generated in 2002 by Laxman et.al45 and used the estrogen 
receptor (ER) sequence to attenuate Flue through steric interactions45. Two 
variants of this reporter were generated; one containing only one copy of the ER 
sequence linked to the carboxy terminus of Flue by a linker containing the 
caspase-3 cleavage sequence DEVD (ER-DEVD-Fluc); and one with two ER
19
sequences on the amino and carboxy termini, respectively (ER-DEVD-Fluc- 
DEVD-ER). Each of the linkers contained the caspase-3 cleavage recognition 
sequence DEVD. ER-DEVD-FLuc was shown to achieve a 50% attenuation of 
Flue activity, while ER-DEVD-Fluc-DEVD-ER almost completely abolished Flue 
activity in comparison to native luciferase. Treatment of D54 glioma cells with 
TNF-a Related Apoptosis Inducing Ligand (TRAIL) showed a dose-dependent 
response of ER-DEVD-Fluc-DEVD-ER, with more efficient cleavage at higher 
doses. Athymic nude mice bearing tumors expressing ER-DEVD-Fluc-DEVD-ER 
showed a 3-fold increase in luciferase activity when administered TRAIL 
intratumorally45. Although this method produced promising results there are a 
number of drawbacks to this technique, most notably that cleavage of ER-DEVD- 
FLuc-DEVD-ER into free luciferase at low TRAIL doses is very inefficient and 
only results in a fraction of the potential signal.
In 2007 a cyclic luciferase reporter was generated by Kanno et al46. This reporter 
silences Flue activity by fusing the N and C ends of the enzyme. Digestion by 
caspase-3 linearizes the reporter and is sensitive enough to detect basal levels 
of caspase-3 activity that are reduced by the pan caspase inhibitor Z-VAD FMK. 
High doses of STS were shown to cause up to an 8 fold increase in luciferase 
activity in COS-7 cells transfected with the reporter46. Reporter activation was 
transient in nature, peaking at 3 h of STS treatment. This group was the first to 
demonstrate a window of activity for caspase-3 enzymatic activity that is transient
in nature.
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In 2008 luciferase-based caspase-3 reporters were generated by two groups. One 
was a tri-fusion multimodality reporter, designed to silence luciferase activity 
using a strategy similar to that used by Laxman et al45. The trifusion reporter 
combines fluorescence imaging, bioluminescence imaging and positron emission 
tomography by fusing the coding sequences for RFP, Flue and thymidine kinase 
(TK) separated by linkers containing the caspase-3 cleavage site. Each of the 
reporter modalities serves the same role as the ER does in Laxman et al’s45 
reporter, causing silencing of all 3 reporters’ activities by steric interactions. The 
trifusion reporter has the same limitations as the ER-DEVD-Fluc-DEVD-ER 
reporter in that the activity of FLuc, TK and RFP cannot be fully restored, 
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Figure 1-3: Schematic Illustrating the construct layout of the 4 FLuc reporters. Construct 1, ER- 
DEVD-FLuc-DEVD-ER silences FLuc activity by linking ER to the N and C termini of FLuc. 
Construct 2 uses the same strategy to silence FLuc, but instead of ER, RPF and TK are used 
attached to the N and C termini. Construct 3 is a cyclic reporter linking the N and C termini to 
each other through a short linker sequence containing the DEVD sequence. Construct 4 
separates the N and C termini of FLuc from each other with 2 peptides, PepA and PepB, and a 
linker region containing the DEVD sequence. Cleavage of all 4 reporters at the DEVD sequence 
by caspase-3 restores FLuc activity.
The caspase-3 reporter used in the present study is illustrated in Figure 1-3 (4) 
and in more detail in Figure 1-4. It utilizes the principle of split luciferase 
complementation that was first demonstrated by Kanno A et.al48 in order to 
detect translocation of mitochondrial proteins into the cytosol48. The N-teminal 
and C terminal sequences of luciferase have been inserted into the construct 
such that the orientation of the N-terminal subunit of the enzyme is in the reverse 
orientation, rendering the enzyme inactive without cleavage. The N and C
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terminal subunits are then fused to two peptides, PepA and PepB49 respectively, 
with a high binding affinity for one another and joined by a linker region 
containing the caspase-3 cleavage site. When caspase-3 is active, the reporter is 
cleaved at the DEVD sequence. After cleavage PepA and PepB bind to each 
other bringing the N and C terminal ends together and restoring enzyme function. 









Figure 1-4: Schematic of ANLucBCLuc Activity In response to Caspase-3 Cleavage. 1) Caspase- 
3 cleaves ANLucBCLuc at the DEVD site. 2) ANLuc and BCLuc with the help of Pep A and Pep B 
form functional Flue and in the presence of ATP and D-Luciferin carries out the light reaction. 3) 
Light is emitted from the reaction and the metabolites (oxyluciferin) are released.
The developers of this construct found that treatment of mice bearing D54 glioma 
tumors with temozolomide, a DNA alkylation and méthylation agent for glioma 
treatment, showed a time and dose-dependent increase in bioluminescence that
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peaked 3 h after treatment. In the validation of the construct, Western blot 
analysis for FLuc showed 2 bands corresponding to ANLuc and BCLuc as a 
result of cleavage of the reporter after 3 h of treatment of D54 glioma cells with 
100 nM staurosporine50. This construct is well characterized and it is for this 
reason that it was chosen for this work.
1.3 Rationale
As previously mentioned, cytokines appear to play a critical role in the 
development of T1DM. In 2003, a microarray study was conducted on INS-1 E 
cells after 1, 2, 4, 6, 8, 12, and 24 h of treatment with IL-1(3 and IFN-y to 
investigate gene networks that are regulated by pro-inflammatory cytokines3. The 
study revealed a number of gene networks that are regulated by this cytokine 
mixture. The most interesting findings with respect to apoptosis are the changes 
in the apoptotic proteins BAD and caspase-3. Within 2 h of cytokine treatment, 
mRNA expression of BAD and caspase-3 increases, then returns to baseline at 4 
h and 8 h respectively3. These findings illustrate the highly dynamic nature of 
apoptosis, but the results focus on the level of gene expression rather than 
protein modification and enzymatic activity. Apoptotic proteins are regulated 
through protein modifications and enzymatic action. Further study of caspase-3 
at early time points has been carried out using traditional biochemical 
techniques, fluorometric and bioluminescence assays51"53. The greatest limitation 
of these studies is that they track changes in enzymatic activity in cell lysates 
collected at set time points. These methods of measurement are static in nature,
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and more importantly may not be reflective of enzymatic kinetics but instead 
measurements of accumulation. Therefore, new techniques and methods have to 
be developed to reliably measure cytokine induced caspase-3 activity in a live 
cell model.
1.4 Objectives
The objectives of this thesis are two-fold:
I. To characterise and validate the use of ANLucBCLuc (caspase-3 reporter) 
as a reliable apoptosis sensor in an in vitro T1DM cell model.
II. To use the caspase-3 reporter in elucidating the mechanisms of caspase- 
3 activation in response to cytokines.
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2 Materials & Methods
2.1 Materials
2.1.1 Cell Model: INS-1/832/13
The clonal cell line INS-1/832/13 was chosen for experiments. This INS-1 clone 
was derived from the parental INS-1 cell line and has been engineered to stably 
express human proinsulin. The insulin secretion and glucose response properties 
are very similar to primary (3-cells in culture, and more specifically, both 
potassium channel-dependent and independent insulin secretion are present in 
this clone54.
2.1.2 Glucagon-Like Peptide 1 (GLP-1)
Glucagon-Like Peptide 1 is secreted in response to food ingestion and results in 
slowing of gastric emptying, stimulation of glucose-dependent insulin secretion 
and overall appetite control. Additionally, as discussed in Section 1.1.3, GLP-1 
has been found to promote (3-cell survival and inhibit caspase-3 activity.
Given the short plasma half-life of GLP-1, exendin-4, a GLP-1 receptor agonist 
isolated from the saliva of the Heloderma spp. with 53% homology to GLP-1 and 
longer plasma stability has been chosen as an inhibitor of apoptosis in selected 
experiments.
2.1.3 General Electric Explore Optix Imaging System
The imaging system used is a GE ExplorOpitx (General Electric) black box that is
equipped for live animal bioluminescence and fluorescence. The image capture 
device relies on a set of photomultiplier tubes that register every photon count as
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a voltage, and raster scans a region of interest with integration times from 0.5-1 s 
and step sizes 1-3 mm. For large regions of interest this can result in long scan 
times. The advantage to this method over a cooled charge coupled device (CCD) 




The clonal rat P-cell line INS-1/832/13 (gift from Dr. Chris Newgard, Duke 
University) was cultured at a 37°C in a humidified incubator containing 5% CO2 
and 95% air. The cells were grown in RPMI-1640 medium (Invitrogen) 
supplemented with 10% FBS (Invitrogen), 50 pM 2-mercaptoethanol (Fisher), 
500 mg/L sodium bicarbonate (Fisher), 110 mg/L sodium pyruvate (Invitrogen), 
and 2.383 g/L HEPES (Fisher) as described by Hoheimer et al54. Cells were 
passaged every 3 days and discarded after 30 passages. In order to passage the 
cells, the medum was aspirated followed by a wash in 37°C Hanks Balanced Salt 
Solution (HBSS) (Fisher). After the wash, 0.05% Trypsin (GIBCO) was applied to 
the cells for 30 s, aspirated and the cells were allowed to sit for 1-2 min. The cells 
were resuspended in 5ml RPMI-1640 and centrifuged at 800 G. The supernatant 
was discarded and the pellet was resuspended then plated 1:10 in 75 mL culture 
flasks (Falcon).
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2.2.2 Collecting Cell Lysates for Western Blotting
INS-1 cells were plated in 6-well dishes at 1x106 cells per well and were
administered their respective treatments after 24 h. Cells were washed twice with 
ice-cold HBSS (Fisher), then collected in 100 pL Tris-EDTA lysis buffer 
containing mini-complete protease inhibitors (Fisher) or 300 pL PhosphoSAFE 
lysis buffer (Merck Chemicals). Protein content in cell lysates was quantified by 
the colorimetric bicinchoninic Acid Assay (BCA Assay, Pierce Thermo Scientific). 
In 96-well plates, protein samples were diluted 1:2 and 1:5 in lysis buffer to a 
volume of 10 pL. The working reagent was prepared according to manufacturer’s 
instructions, added to the protein samples and allowed to incubate for 30 min at 
37°C. The resulting colour change was measured in a plate reader by taking 
absorbance values at 575 nm, and was compared to a known protein standard to 
determine concentration (25-2000 pg/ml).
2.2.3 Transfection Efficiency
In order to assess transfection efficiency, INS-1 cells were plated in a 35 mm 
dish and transfected with eGFP using Lipofectamine 2000 (Invitrogen) according 
to the manufacturer protocol. After 48 h the cells were trypsinzed and 
resuspended in 500 pL RPMI-1640 without phenol red (Invitrogen) in preparation 
for flow cytometry. Untransfected cells were passed through a flow cytometer in 
order to distinguish between INS-1 cells and debris. Once the size and object 
complexity boundaries were established (forward and side scatter), the 
transfected cells were passed through the flow cytometer, and measured for GFP
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fluorescence. A total of 10,000 events were counted for Control and eGFP, and a 
percentage of GFP positive cells was calculated for each group.
2.3 Bioluminescence Imaging
INS-1 cells were plated in a 24 well plate at 2.5x105 cells per well and transfected 
with the bioluminescent caspase-3 reporter (gift from Dr. Alnawaz Rehemtulla, 
Univeristy of Michigan) described in the introduction section 1.2.4 using 
Lipofectamine 2000 as per manufacturer’s instructions. After 24 h, the media 
were changed and following another 24 h the cells were prepared for imaging. 
Immediately before imaging, cells were treated with 10 ng/ml IFN-y, 10 ng/ml IL- 
1(3 and 50 ng/ml TNF-a (Sigma). The cells were imaged in a General Electric 
Healthcare Explore Optix optical scanner every 2 h for 6 h (N=5). Fresh firefly D- 
luciferin (Xenogen) was added to the wells at a final concentration of 150 pg/ml 
at each time point. The optical scanner collected data over the region of interest 
at a rate of 1 mm/s with a 1 s integration time, and obtained a photon count at 
each point. Photon counts are registered with a photomultiplier tube that 
amplifies a single photon collision into a voltage. The scanner software then 
forms an intensity colour map that is representative of the photon flux over the 
area scanned. The data were normalized to the baseline image and presented as 
bioluminescence (x baseline) vs Time (Mean ± SEM). For statistical analysis, a 
conservative approach was used in order to minimize the chances of Type I 
error. A 2-factor Analysis of Variance with Bonferroni correction (a=0.05) was 
performed with pairwise comparisons for time and group (control/cytokines).
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2.3.1 Pulse Chase: Effects of temporary inflammation on caspase-3
In order to determine the short-term effects on caspase-3 after removal of
cytokines, INS-1/832/13 cells were incubated in 10 ng/ml IFN-y, 10 ng/ml IL-1(3 
and 50 ng/ml TNF-a for 1 h following a baseline image. The media were changed 
without a wash and the cells were imaged 0 h and 3 h after cytokine removal 
(N=4). Bioluminescent images were analyzed using the GE Optiview software 
native to the scanner. The data were normalized to the baseline image and 
presented as bioluminescence (x baseline) vs Time (Mean ± SEM). These data 
were analyzed by One-Way ANOVA and post hoc Tukey test with significance 
set at 0.05.
2.3.2 Bioluminescence imaging with Exendin-4
In order to determine how GLP-1 affects early caspase-3 activation in INS-1 
cells, cells transfected with ANLucBCLuc were pre-incubated overnight in 20 nM 
exendin-4 (Bachem), a GLP-1 analogue found in Heloderma spp. The cells were 
then treated with 10 ng/ml IFN-y, 10 ng/ml IL-1 (3 and 50 ng/ml TNF-a and imaged 
every 2 h for 6 h (N=4). Bioluminescent images were analyzed using the GE 
Optiview software native to the scanner. For each experiment, an average 
photon count over 4 wells in a 24 well plate was taken for each time point. These 
results were normalized to the baseline image and a global mean was calculated 
for all treatments. The results were plotted as Bioluminescence vs. Time (Mean ± 
SEM). These data were analyzed by Univariate ANOVA and post hoc Tukey 
tests with significance set at 0.05.
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2.3.3 Examining the Roles of Intrinsic & Extrinsic Apoptotic 
Pathways in Early Caspase-3 Activation
The combination of proinflammatory cytokines used in the experiments described
above reliably induces apoptosis. The combination works through both the 
intrinsic and extrinsic apoptotic pathways. More specifically, TNF-a induces cell 
death mediated by the extrinsic pathway, and both IL-1(3 and IFN-y work through 
the intrinsic pathway. In order to determine the role that each pathway plays in 
the early activation of caspase-3, transfected INS-1 cells were treated with either 
10 ng/ml IFN-y and 10 ng/ml IL -ip  or 50 ng/ml TNF-a. The cells were then 
imaged every 2 h for 4 h (N=3). Results were analyzed by 2-factor ANOVA with 
post hoc Tukey’s Test when significance was found.
2.4 Western Blots
2.4.1 BAD
Cell lysate protein, 50 pg, collected after 0, 2 and 4 h of cytokine treatment in the 
absensce or presence of exendin-4 were separated by 12% SDS-PAGE. The 
protein was dry transferred onto nitrocellulose membranes using the Invitrogen 
dry transfer apparatus. The membranes were stained with Ponceau S diluted 
1:1000 in 5% acetic acid to ensure equal loading, even migration and protein 
integrity before blocking with 5% Bovine Serum Albumin (BSA, Fisher Scientific). 
The primary antibody for BAD (Cell Signaling) was concentrated 1:1000 in 5%
BSA.
31
2.4.2 Caspase-3 & 9
Cell lysates were collected after 0, 2 and 4 h of treatment with cytokines (TNF-a, 
IFN-y, IL-1|3) in the absence or presence of exendin-4 and 50 pg of protein were 
loaded into each well and separated by 10% SDS-PAGE. The blots were blocked 
in 5% non-fat dry milk (casein protein) + Tris Buffered Saline with 0.05%Tween- 
20 (TBS-T, Fisher) then incubated at 4°C overnight in (1:1000) rat a-rabbit full 
length caspase-3 and rat a-mouse cleaved caspase-9 (Cell Signaling) antibodies.
2.4.3 Firefly Luciferase
Cell lysate protein, 20 pg, collected at 0 h, 0.5h and 2 h of cytokine treatment 
were separated by 8% SDS-PAGE. The blot was blocked in 5% non-fat milk in 
0.05% TBS-T and probed overnight at 4°C with a-luciferase antibody (Cell 
Signaling) 1:10,000. Secondary antibody was applied at a concentration of 
1:10,000 according to the protocol described in 2.4.4.
2.4.4 Secondary Antibody
After removing the solution containing the primary antibodies, the blots were 
washed 3 times for 5 min with TBS-T and once with TBS to discard any unbound 
primary antibody. The blots were then incubated in either anti-rabbit or anti­
mouse Horse Radish Peroxidase (HRP) (1:5000) for 1 h at room temperature. 
The blots were washed twice for 5-10 min in TBS-T and once in TBS before 
incubating for 5min in Super Signal (Pierce). The blots were visualized using 
GeneSnap software for the SynGene Chemiluminescence Documentation
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System. Images of the blots were captured in GeneSnap and then analyzed in 
GeneTools (SynGENE).
2.4.5 Densitometry Analysis
The GeneTools software generates a histogram for each band on the 
nitrocellulose membrane. In order to determine the density of the bands, the area 
under the peaks of the bands corresponding to the cleaved forms of caspase-3 
and 9 were compared to those of the full length product at each time point as a 
ratio of cleaved caspase: uncleaved caspase. The results were plotted as an 
intensity vs. time graph (N=3) (Mean ± SEM). BAD was normalized to P-actin 
loading control.
2.5 Im m u n o c y to c h e m is try
INS-1 cells were lightly plated on a cover slip (~50-60% confluent), fixed and 
made permeable in 2% paraformaldehyde and 0.25% Triton-X-100 solutions in 
Phosphate Buffered Saline (PBS) (Fisher) respectively. They were incubated 
overnight with rat a-rabbit cleaved Poly Adenosine Ribose Polymerase-1 (PARP) 
(1:100) primary antibody at 4°C. The Alexa 594 labelled secondary antibody was 
applied (1:500) for 1 h and then incubated in Hoescht 33342 (Sigma) 1:5000 for 
5 min in order to stain the nuclei then the cover slips were fixed to slides.
Ten randomly selected fields of view were taken from three slides for each 
treatment. All images were taken at 400X total magnification through the DAPI 
(blue) and TRITC (red) channels on an Olympus 1X81 microscope. The images 
were then pseudo-coloured and overlaid in Adobe Photoshop. In order to define
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PARP-positive nuclei, cells in which both TRITC and DAPI nuclear staining were 
co-localized were counted. One hundred nuclei were randomly counted in 10 
fields of view for each treatment, and PARP-positive nuclei were taken as a 
percentage of the total number of nuclei. The data were analyzed by 2 factor 
ANOVA with Group and Time as the factors and were followed by post hoc 
Tukey’s tests.
2.6 Fluorescence Imaging (Live Cells)
2.6.1 Mitochondrial Membrane Permeability
The mitochondrial dye JC-1 is taken up by the mitochondria and forms J- 
aggregates that fluoresce red. When the mitochondria are damaged they 
become ‘leaky’ resulting in JC-1 flowing down the concentration gradient into the 
cytosol. At the low concentrations found in the cytosol, JC-1 returns to the 
monomeric form that fluoresces green. In order to investigate how cytokines 
affect mitochondrial membrane permeability, a change that occurs prior to 
caspase-3 activation by the intrinsic apoptotic pathway, 4 types of experiments 
were conducted. INS-1 cells were incubated in 25 nM JC-1 (Invitrogen) for 1 h35. 
The media were removed and replaced without rinsing. Cells were treated with 
vehicle, 10 ng/ml IFN-y, 10 ng/ml IL-1(3 and 50 ng/ml TNF-a, 10 ng/ml IFN-y and 
10 ng/ml IL-1 (3 or 50 ng/ml TNF-a and images were collected every 20 min for 4 
h on an Olympus 1X81 microscope equipped for live cell imaging with TRITC and 
FITC filters (Alexa 594 and Alexa 488). The Alexa 594 channel was set to a gain 
and exposure time such that the signal was as high as possible before pixel
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saturation in the camera. The Alexa 488 channel was set such that the total 
fluorescence on the first image was approximately equal to that of the Alexa 594 
channel. A ratio of green fluorescence (Alexa 488) to red fluorescence (Alexa 
594) was taken at each time point and normalized to the first image to yield a 
percent change in fluorescence (N=3). These results were analyzed by 2-Factor 
Repeated Measures ANOVA with 13 levels at a significance of 0.05. The time 
curves were integrated to yield and area under the curve (AUC) for each 
treatment. The AUC data were analyzed by Kruskal Wallis Test, a nonparametric 
statistical analysis of variance due to small sample size and unequal variances 
between groups.
2 .7  Im a g e  A n a ly s is
Fluorescence images were analyzed in Image J 1.40g. Measurements of 
integrated density (total fluorescence) in Alexa 594 and Alexa 488 images were 
taken for each time point. A ratio of Alexa 488 to Alexa 594 values was taken and 
was normalized to total fluorescence at time zero (T0=1). Results were reported 
as Fluorescence vs. Time graphs (Mean ± SEM).
2 .8  D N A  F ra g m en ta tio n  A s s a y
DNA fragmentation is an important end stage marker of apoptosis. INS-1 cells 
were plated at an area density of 1x106 per each well of a 6 well dish and 
received treatments of 10 ng/ml IFN-y, IL-1J3 10 ng/ml and TNF-a 50 ng/ml for 24 
h or 10 ng/ml IFN-y and 10 ng/ml IL-1 (3 or 50 ng/ml TNF-a for 24 h.Cells were 
trypsinized according to the protocol previously described then the cells were
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lysed and collected in incubation buffer provided in the Cell Death Detection Kit 
(Roche). The cell lysate was spun for 15 min at 16,000 G in order to separate 
fragmented DNA from the larger cell components and the supernatant was 
placed in a fresh tube. An aliquot of 100 pL was taken from each sample for 
protein quantification by BCA Assay as described in 2.2.2. The wells of a 96 well 
plate were coated with a coating solution containing anti-histone antibodies for 90 
min then washed 3 times with the washing buffer provided in the kit. After 
washing the wells, 100 pL of sample was added to each well and allowed to 
incubate for 90 min. The wells were washed 3 times and then conjugate solution 
containing anti-DNA antibody and were added to each well for 90 min. The wells 
were washed 3 times then the substrate solution was applied to each well and 
shaken at 225 RPM for 15 min. Absorbance readings were taken at 405 nm and 
each reading was normalized to the protein concentration of each sample. The 
results were presented as 3 graphs, Absorbance/pg protein vs Treatment, 
Protein concentration vs Treatment and Absorbance vs Treatment (Mean ± SEM) 
(N=3). The results were analyzed by One-Way ANOVA with post hoc Tukey tests 
when significance (a=0.05) was found. The protein data and DNA data were 
analyzed individually by One-Way ANOVA. The protein data failed Levene’s test 
of homogeneity of variance and were therefore analyzed by Kruskal Wallis test.
2 .9  S ta tis tic a l A n a ly s is
All Statistical analysis was done using the PAWS 18 Statistical Package.
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3 Results
I conducted all experiments herein, with the exception of the Western blot in 
Figure 3-2 which was done by Rebecca McGirr, research technician.
3.1  IN S -1 /8 3 2 /1 3  T ransfec tion  E ffic ie n c y
In order to quantitatively assess the level of transfection, INS-1/832/13 cells 
transfected with eGFP were trypsinized and counted by flow cytometry. Based on 
forward and side scatter profiles, objects contained by the pink boxes in Figure 2- 
1 panels A and C were defined as cells and counted for GPF fluorescence. This 
experiment revealed a level of transfection at 25.5% (Figure 3-1D). Additionally, 






















Figure 3-1: Quantitative Assessment of Transfection Efficiency. Objects within the pink boxes A,C 
were defined as cells. Quantification of GFP positive cells showed 0.043% GFP positive in 
untransfected cells (B) and 25.5% in transfected cells (D). There is a wide range of GFP 
intensities in the GFP positive cells.
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3 .2  E x p ress io n  a n d  V alidation  o f  the C aspase-3  L u c iferase  
R e p o rte r
Pro inflammatory cytokines have been shown to cause significant apoptosis in 13- 
cell models. INS-1 cells transfected with ANLucBCLuc were treated with the 
proinflammatory cytokine cocktail described in the Methods section (IFN-y, IL-1(3 
and TNF-a). In order to ensure that the ANLucBCLuc protein was being cleaved, 
qualitative Western blot analysis on lysates from cells transfected with 
ANLucBCLuc and treated with cytokines for 0, 0.5 and 2 h showed that the 
construct was cleaved at 2 h of treatment. Two bands corresponding to the 






Figure 3-2: Confirmation of reporter cleavage by Western blot: Bands correspond to luciferase 
expression of cell lysates collected at 0 h, 0.5h and 2 h of cytokine treatment. After 2 h of cytokine 
treatment, bands corresponding to the cleaved fragments of the luciferase reporter are apparent.
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Once cleavage of the reporter was confirmed by Western blot, transfected INS-1 
cells were treated with the cytokine mixture and images were taken every 2 h 
until 6 h. Figure 3-3A shows representative images taken at 0-6 h in control and 
cytokine treated cells. Cytokine treatment resulted in an increase in 
bioluminescence that peaked at 4 h and began to drop at 6 h. Quantification of 
the bioluminescence results illustrated in Figure 3-2B showed an increase that 
peaked at 4 h then returned to baseline by 12 h. Bioluminescence in the cytokine 
treated group was significantly different from the control group (p<0.05) and the 
effect was seen at 4 h of treatment (p<0.05).
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Figure 3-3: Live Imaging of Caspase-3 In Response to Cytokines.(A) Raw images of Control and 
Cytokine treated INS-1 cells from 0-6 h. Colour bar represents photon counts/s. Increase in 
bioluminescence begins at 2 h of cytokine treatment peaking at 4 h and beginning to decrease at 
6 h. (B)Quantification of bioluminescence from live cell imaging is representative of 5 independent 
experiments presented as mean ± SEM. There is a peak in bioluminescence at 4 h (p<0.05) with 
cytokine treatment.
3 .3  P u lse  C hase: E ffec ts  o f  tra n s ie n t in flam m atio n  on caspase-3  
a c tiv ity
The effects of an acute cytokine insult were explored through a pulse chase 
experiment. After a baseline image had been acquired, cells were treated with a 
1 h pulse of cytokines and imaged immediately after and 3h following the pulse.
The imaging results were analyzed by one way ANOVA. Immediately after the 
pulse, there was no change in bioluminescence (p<0.05) but at 4 h there was a 
significant increase (p<0.05) in bioluminescence.
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Figure 3-4: Live Cell imaging of the Effects of a Short Cytokine Pulse. The images are 
representative images of the baseline, 0 h after a 1 h cytokine pulse and 3 h after the cytokine 
pulse. Colour bar represents photon counts/s. The caspase-3 reporter is activated 3 h after the 
cytokine pulse. The graph is a quantification of the pulse chase images. Bars represent mean ± 
SEM of 4 independent experiments. There was a significant increase in bioluminescence three 
hours after the removal of cytokines (p<0.01).
3.4  E ffec ts  o f  E x en d in -4 /G L P -1  on cy to k in e  In d u c e d  A p o p to s is
GLP-1 and exendin-4 are known to promote glucose-dependent insulin secretion,
and inhibit apoptosis in (3-cells. In order to determine the effects of exendin-4 on 
caspase-3 activity in real time, bioluminescence imaging was carried out on INS- 
1/832/13 cells that were treated with cytokines either in the absence or presence 
of 10 nM exendin-4. There was a significant increase in bioluminescence in the 
cytokine treated group at 2 h and 4 h (p<0.01) as illustrated in Figure 3-4B.
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Exendin-4 significantly (p<0.05) attenuated the action of cytokines, but did not 







Figure 3-5: Live cell imaging of the Effects of Exendin-4 on Cytokine induced Apoptosis. (A) 
Representative images of the effects of exendin-4 preincubation on caspase-3 activation. Colour 
bar represents photon counts/s. Cytokines cause an increase in caspase-3 reporter activity and
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exendin-4 preincubation attenuates the magnitude of that activation. (B) Quantification of 4 
independent experiments as a mean ± SEM. Cytokines cause a significant increase in 
bioluminescence at 2 and 4 h. The presence of exendin-4 significantly attenuates cytokine 
induced activity denoted by #.
In order to confirm caspase-3 cleavage, Western blot analysis for cleaved 
caspase-3 was performed on cell lysates collected at baseline, 2, 4, 6 and 12 h 
following cytokine treatment (N=3). An increase in cleaved caspase-3 was 
observed over time and peaked at 6 h (Figure 3-5A). The level of caspase-3 
cleavage was significant at 4 h (p<0.05) and 6 h (p<0.01) of cytokine treatment 
relative to baseline (Figure 3-5B). Cleaved caspase-3 was not detected in cell 
lysates treated with exendin-4.
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Figure 3-6: Western Blot Analysis of Caspase-3 cleavage by cytokines in the absence or 
presence of exendin-4. Panel A shows the raw blots of cell lysates treated with cytokines in the 
absence or presence of exendin-4. In the absence of exendin-4, caspase-3 cleavage increases
44
and peaks at 6 h before returning to near baseline levels. Quantification of the bands is shown in 
Panel B. The increase in caspase-3 cleavage is significant at 4 h but reaches maximal 
accumulation at 6 h. Cleaved caspase-3 was not detected in the presence of exendin-4.
Western blot analysis of caspase-9 and BAD, elements upstream of caspase-3 in 
the intrinsic pathway, was performed to determine the manner in which exendin-4 
inhibits caspase-3. The blots in Figure 3-7 and 3-8 showed no appreciable 
changes with cytokine treatment. In the presence of exendin-4, cleaved caspase- 
9 was not detected. BAD was detected both in the absence and presence of 
exendin-4. Quantification of cleaved caspase-9 and total BAD (Figures 3-7 & 3-8) 
showed no significant changes over time.
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Figure 3-7: Western Blot analysis of the effects of exendin-4 on Caspase-9. In the absence of 
exendin-4 caspase-9 and cleaved caspase-9 were detectable but no changes were observed
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over the time course. Densitometry analysis showed no significant changes in caspase-9 
cleavage over the time course (bars represent Mean ± SEM). In the presence of exendin-4, 
caspase-9 protein was not detected.
-exendin-4 




0 2 4 6 12
BAD 23KDa 
Actin 42KDa
■  Cytokines 
£3 Cyto +exendin4
2 4 6 12
Time (h)
Figure 3-8: Western Blot analysis of the effects of exendin-4 on BAD. The blots show that BAD 
was detected in the absence and presence of exendin-4. There were no appreciable changes 
over time. Densitometry analysis showed that there were no significant changes over the time 
course and that there were no differences in BAD protein in the absence or presence of exendin- 
4 (Bars represent Mean ± SEM).
Immunocytochemistry for cleaved PARP, a product of caspase-3 cleavage, 
further confirmed that pro-inflammatory cytokines cause caspase-3 dependent 
apoptosis. Cells in which cleaved PARP co-localized with the nucleus were 
detected in both control and cytokine treated groups at 0, 2 and 4 h (Figure 3- 
9A). The percentage of cells with c-PARP co-localization were significantly higher 
in control (p<0.01) and 2 h (p<0.01) cytokine treated groups compared to the 4 h
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cytokine treatment and did not differ significantly from one another (Figure 3-8D). 
In the presence of exendin-4, there were no appreciable changes in the 
percentage of c-PARP positive nuclei with respect to time and there were 
significantly fewer c-PARP positive nuclei when compared with the cytokine 
treated group (p<0.01)(Figure 3-9A,B,D). Maximum PARP cleavage was 
observed at 2 h of cytokine treatment and decreased significantly at 4 h of 
cytokine treatment(p<0.05). There were no significant changes in cell 
morphology at either time point. Images were also collected at 24 h of cytokine 
treatment in the absence of exendin-4, and there were no c-PARP positive nuclei 
observed; instead, the cells displayed disrupted cell morphology, characterized 
by abnormal nuclei. (Figure 3-9C)
3 .5  E x p lo rin g  the N atu re  o f  C ytok ine  In d u c e d  A p o p to s is  w ith  
Im a g in g
Proinflammatory cytokines (IL-1 (3, IFN-y & TNF-a) have been shown to induce 
apoptosis and caspase-3 activation in various combinations of the three. The 
relative contribution of each cytokine to the final activation of caspase-3 is not 
well known. I hypothesized that imaging the effect of separating out the cytokines 
into their respective pathways might yield their relative contribution to apoptosis. 
Transfected INS-1 cells were treated with TNF-a only, IL-ip+IFN-y or all three 
cytokines and imaged for 4 h. Bioluminescence in the groups treated with IL- 
1(3+IFN-y+TNF-a and IL-1 (3+IFN-y was significantly increased (p<0.01) when 
compared with TNF-a treated cells, but IL-1 (3+IFN-y and IL-1f3+IFN-y+TNF-a did
not differ from one another.
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Figure 3-9: Immunocytochemistry for the effects of cytokines and exendin-4 on Caspase-3 
substrate PARP. Panel A shows representative images of PARP cleavage in response to 
cytokines in the absence of exendin-4. At control the majority of cells have c-PARP localized to
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the nucleus. After 2 h of cytokine treatment the number of c-PARP positive nuclei increases and 
then decreases at 4 h. Panel B shows representative images of PARP cleavage in response to 
cytokines in the presence of exendin-4. In control, 2 h treated and 4 h treated cells there are very 
few cells showing c-PARP in the nucleus. In the absence and presence of exendin-4 at control, 2 
h and 4 h of cytokine treatment, cells show normal nuclear morphology. Panel C shows the 
effects of cytokines in the absence of exendin-4 over 24 h. C-PARP does not co-localize with the 
nucleus, and all cells show disrupted nuclear morphology. Panel D shows quantification of c- 
PARP positive nuclei under control and exendin-4 treated conditions over 4 h of cytokine 
treatment.
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Figure 3-10: Bioluminescence imaging of the intrinsic and extrinsic pathway effects on caspase-3. 
(A) Representative images of cytokine treated, IL-1(3+IFN-y and TNF-a only. Colour bar 
represents photon counts/s. The cytokine treated cells have increased bioluminescence at 4 h 
which is slightly greater than in the IL-1(3 + IFN-y treated group. TNF-a caused no change. 
Quantification of bioluminescence (B) revealed that cytokines and IL-1 (3 + IFN-y significantly 
increased caspase-3 activity compared to TNF-a (p<0.01) but did not differ from each other.
Changes in mitochondrial permeability precede casapse-3 activation by the 
intrinsic pathway of apoptosis. I used the fluorescent mitochondrial dye JC-1,
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described in section 2.6.1, to monitor changes in mitochondrial membrane 
potential. JC-1 localizes to the mitochondrial intermembrane space and forms J- 
aggregates at high concentrations. These J-aggregates fluoresce red and 
dissociate into the monomeric form that fluoresces green upon the 
permeabilization of the mitochondrial membrane. Following a 1 h incubation in 
JC-1, INS-1 cells received treatment with either TNF-a, IL-1(3+IFN-y or all 3 
cytokines together, and images were collected every 20 min for 4 h. The ratio of 
green to red fluorescence increased 2.5 fold in the cytokine treated group at the 
end of the 4 h time course, while IL-1 p+IFN-y increased 1.26 fold. TNF-a 
treatment on its own caused no change. Changes in mitochondrial permeability 
of the cytokine group were significantly different from control (p<0.01), IL- 
1 (B+IFNy (p<0.01) and TNF-a (p<0.01). Mitochondrial permeability changes did 
not differ significantly between control and TNF-a only and IL-1 p+IFN-y treated 
groups. The data were integrated into area under the curve (AUC) plots (Figure 
3-1 OB) and analyzed with Kruskal Wallis Test. The distribution of AUCs was 
significantly different (p<0.05) across groups.
DNA fragmentation is a marker of end stage apoptosis. In order to confirm that 
the cytokine treatments were inducing apoptosis, DNA fragmentation analysis on 
samples subjected to the previously mentioned treatments for 24 h revealed 
significant changes in protein concentration (p=0.049) but no differences in 
fragmented DNA. When normalized to protein, no significant differences were 
found when means were analyzed by One-Way ANOVA. It must be noted that
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the groups treated with Cytokines and IL-1(3+IFN-y had the highest levels of DNA 
fragmentation while the TNF-a treated group had near basal levels of DNA 
fragmentation (Figure 3-12) but all groups were highly variable. The distributions 
of protein concentration did not differ significantly and DNA absorbance was 
equal through all samples (see figure 3-12 B, C).
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Figure 3-11: Examination of Mitochondrial Permeability in response to various cytokine 
combinations. A) Representative images of JC-1 fluorescence before and 4 h after administration 
of the cytokine treatments. Ratios of Green to Red fluorescence were taken for each time course 
and normalized to their baseline image, A curve was generated for each treatment, and 
integrated to yield an Area Under the Curve. B) AUC quantification. Kruskal-Wallis test revealed 





Figure 3-12: DNA Fragmentation Analysis of Cytokine Induced Apoptosis. A quantification of 
absorbance readings taken at 405nm in response to a 24 h treatment with Cytokines, TNF-a and 
IL-1(3 + IFN-y as a measure of DNA fragmentation. There were no significant differences found 
between groups when DNA was normalized to protein concentration. Protein data (C) and DNA 
data (B) were analyzed separately. There were no significant differences in protein content while 
DNA content was equal.
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4 Discussion
In this study I characterized the response of the bioluminescence caspase-3 
reporter, ANLucBCLuc, to various cytokine treatments in INS-1 /832/13 clonal 
cells. This was accomplished by comparison to Western blot analysis, 
fluorescence imaging and DNA fragmentation analysis of early and terminal 
events in apoptosis. The objectives of this thesis were 1) to characterise and 
validate the use of ANLucBCLuc (caspase-3 reporter) as a reliable apoptosis 
sensor in an in vitro T1DM cell model and 2) to elucidate the mechanisms of 
caspase-3 activation in response to cytokines. I demonstrated that imaging 
ANLucBCLuc activity in response to cytokines provides a highly specific and 
quantitative measure of caspase-3 activity that is more sensitive than western 
blot analysis. I also showed that caspase-3 activity in INS-1/832/13 cells is 
transient in nature, not sustained as has been shown in other cell types and 
measurement systems. With respect to the second objective I showed that 
exendin-4, a known caspase-3 inhibitor, attenuated caspase-3 reporter activity. 
In addition I showed that the intrinsic pathway of apoptosis is the driving force 
behind (3-cell destruction by cytokines, a finding that is consistent with the 
literature.
Although the use of the ANLucBCLuc caspase-3 reporter along with our imaging 
system provides reliable results, there are some practical limitations to the 
system. Firstly, I demonstrated a 25% transfection efficiency, a limitation that can 
be overcome by selecting a stably transfected population. Secondly, the GE
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Explor Optix imaging system is not equipped with a CO2 tank and humidity 
chamber. These are necessary for maintaining a healthy cell population without 
removing the cells from the Explor Optix machine. Combined with the long scan 
times, and the inability to keep the cells in the Explor Optix machine, the 
frequency at which images could be collected was reduced, ultimately limiting the 
temporal resolution. Third and finally, integration times for each image also 
decreased the temporal resolution. Ultimately, the selection of cells that stably 
express the caspase-3 reporter would be the most cost effective method of 
addressing all three limitations. The increased signal from increased expression 
would decrease integration times for imaging and would allow for better temporal 
resolution.
Bioluminescence expression systems have been previously used to monitor islet 
graft survival and rejection. More specifically Chen X et al55 have transplanted 
islets from a mouse expressing FLuc driven by the rat insulin promoter II into 
diabetes induced mice55. They were able to detect transplanted islets and track 
changes in bioluminescence as islet viability decreased. The bioluminescence 
intensities were inversely correlated with changes in serum glucose over a 5 day 
period55. These changes correspond to a loss in islet cell number that represents 
a time point likely too late for intervention. Having an earlier marker of apoptosis 
in such a scenario would be useful. To date the performance of bioluminescent 
caspase-3 reporters has not been tested in a (3-cell model. The performance of 
the ANLucBCLuc reporter is similar to the other bioluminescent caspase-3
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reporters that have been reported in that their activity appears transient in 
response to an apoptotic stimulus46,50. Kanno et al46 have shown with their cyclic 
luciferase caspase-3 reporter that the peak of bioluminescence in response to 
STS is consistently around 2 h in HeLa cells expressing the reporter46. One 
caveat to their reporter is that the temporal kinetics appear to be dose 
dependent, as increasing doses shift the peak in bioluminescence to later time 
points. This effect was noted to be strongest after treatment with potent antitumor 
reagent, actinomycin D, with which a 1000 nM dose caused a peak 
bioluminescence shift from 120 min to approximately 250 min as compared with 
a 100 nM dose46. Coppola et al50 have demonstrated that ANLucBCLuc reaches 
peak activity at approximately 4 h of treatment with TMZ with the timing being 
independent of dose50. Coppola et al50 found no less than a 5-fold increase in 
bioluminescence in all their treatments50 while we did not have more than a 4-fold 
increase in response to cytokines. This difference is likely due to the differences 
in cell type and cell toxins. My goal was to detect apoptosis in cells with an 
established cytokine treatment protocol in order to establish the strength of the 
reporter and imaging strategy. I was successful in this respect, as I was able to 
detect caspase-3 reporter activity with cytokine treatment and reduced levels of 
caspase-3 activity in the presence of the caspase-3 inhibitor exendin-4. Western 
blotting showed no detectable levels of cleaved caspase-3 in the presence of
exendin-4.
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When comparing our reporter and imaging protocol with fluorescent caspase-3 
reporters the major difference is the irreversible nature of the fluorescent 
reporters. With the exception of the FRET based approaches, the fluorescent 
reporters all relied on the translocation of a fluorophore to the nucleus after 
caspase-3 cleavage39 40. A major advantage to the fluorescent reporters is that 
the technology to exploit their strengths is readily available, in the form of 
compound microscopes. Most importantly, these microscopes can easily be 
equipped with incubation chambers for live cell imaging. As a result, they can 
achieve much greater spatial resolution than with bioluminescence techniques 
and can collect images more frequently. However, the properties of the 
bioluminescent caspase-3 reporter construct enable a great deal of versatility in 
experimental design.
4.1 Cytokines Transiently Activate Caspase-3 in INS-1/832/13 
Cells
The most important and interesting finding from this study is that exposure of 0- 
cells to cytokines induces a transient increase in caspase-3 activity. 
Bioluminescence imaging quantitatively showed a transient increase in 
bioluminescence that peaked within 4 h of cytokine treatment (Figure 3-3). 
Western blot analysis for caspase-3 showed a transient cleavage of caspase-3 
that peaked at 6 h, which was 2 h after the observed peak in bioluminescence 
activity (Figure 3-6). The imaging allows the capture of changes in caspase-3 
activity sooner than by Western, as it is more a measure of activity than 
accumulation. The bioluminescence and Western data are in contrast to previous
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studies on the effects of cytokines in INS-1 cells. More specifically, Western blot 
analysis and in vitro luciferase assays in response to treatment with cytokines 
showed an increase in caspase-3 cleavage and activity that was sustained over 
days or hours51'53. Inconsistencies between my results and the literature may be 
due to the fact that the in vivo imaging enabled repeated imaging in the same cell 
population of cells and that the INS-1/832/13 cell line is clonal. In contrast, the 
cell populations used in references [51'53] are parental INS-1 cells, NIT cells and 
in primary islets, which are heterogeneous populations. With respect to INS-1 
cells, Collier J et al56 has demonstrated that different clones of INS-1 cells display 
different responses to apoptotic stimuli and Hohmeier et al54 in their isolation of 
the INS-1 832/13 clone noted that the parental INS-1 cells may in fact represent 
a mixture of endocrine cells with distinct phenotypes54,56 Additionally, in previous 
studies, each time point represented a sampling of a different population of cells, 
resulting in a “snapshot” of caspase-3 activity at a particular time. With in vivo 
imaging, I was able to measure caspase-3 activity continuously in the same cell 
population. The results of these experiments may speak to the nature of not only 
the INS-1/832/13 cell line but also activatable luciferase reporters. Early and 
transient activation of the caspase-3 reporter was reported in the original 
publication of this reporter and also with the cyclic caspase-3 luciferase reporter 
in response to an apoptotic stimulus 46,50. These findings, in conjunction with 
those in the present study, suggest that there is an optimal window to capture 
caspase-3 activity in apoptosis that in vitro assays do not effectively capture. The
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results of my bioluminescence experiments and Westerns are consistent with the 
data from the Kutlu et al3 microarray study which show an early and transient 
increase in caspase-3 mRNA with cytokine treatment3.1 further confirm that 
caspase-3 activation is an early event in cytokine induced apoptosis of (3-cells. 
This study is the first to demonstrate the kinetics of cytokine induced caspase-3 
activity in 1) a clonal (3-cell population and 2) the same cells over time.
4.2 A Short duration of Inflammation causes Caspase-3 activity 
in INS-1 cells
The initiation of caspase-3 activity in response to a constant cytokine exposure 
has been extensively demonstrated but the long term responses to short 
exposures to cytokines have not been investigated in previous studies. My study 
has shown that a 1 h pulse of cytokines induced caspase-3 activation 3 h after 
the removal of cytokines (Figure 3-4). The ability of cytokines to induce caspase- 
3 activity with such short exposures demonstrates that the initiation of apoptosis 
only requires a brief initial stimulus to initiate the cascade. More importantly, it 
demonstrates that an early injury to the (3-cells can result in cell death long after 
the initial insult has disappeared. There have been cases reported of 
spontaneous T 1 DM development after infection by Enteroviruses57. The 
Coxsackie B viruses in particular, have been identified as environmental risk 
factors for T1DM development. Recently, a prospective study conducted on 
prediabetic children 0-10 years old identified through serological studies that 
enteroviral RNA was a risk factor and predictor of clinical T1DM development58. 
Furthermore, a study that characterized the T-cell response to Coxsackie virus
proteins found that in chronically diabetic patients and in newly diagnosed 
patients, T-cells respond by the production of IFN-y and not by proliferation59. 
Interferon-y induces secretion of the chemokine IFN-y-inducible protein 10 (IP- 
10) CXCL10, which recruits leukocytes from the blood to the site of injury. This 
chemokine is increased in the serum of newly diagnosed Type 1 diabetics, and in 
high risk patients when compared with normal controls, low risk patients and 
patients with long standing diabetes60. This reaction to infection by the P-cell is 
likely critical to the initiation of insulitis. A recent study61 demonstrated an 
increase in expression of CXCL10 in human islets following treatment with IFN-y, 
an effect that is reduced by exendin-461. Interestingly, there was a 700-1000 fold 
increase in mRNA levels of CXCL10 in islets in response to the combination of 
IL-1(B, TNF-a and IFN-y. In contrast, treatment with IFN-y alone caused a 200- 
500 fold increase 61, suggesting a synergism in the actions of the cytokines.
Since the development of T1DM is linked to caspase-3-dependent apoptosis 15, 
the production of IFN-y by T-cells in response to pancreatic viral infection and 
increased secretion of CXCL10 may be the critical steps in priming the immune 
system with (3-cell antigens and initiating insulitis development. My results taken 
within this context thus suggest that in an in vivo setting, a brief insult that causes 
a reaction with pro-inflammatory cytokines may be sufficient to initiate insulitis. In 
order to further explore this mechanism, a transgenic mouse expressing the 
ANLucBCLuc construct in (3-cells and our imaging set up would be an excellent
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way to monitor disease progression after infection and clearance of 
enteroviruses.
4.3 The Role of Exendin-4 in Protection against Cytokine 
induced Apoptosis
In an effort to test the responses of the bioluminescent caspase-3 reporter and of 
proteins upstream of caspase-3 in the intrinsic apoptotic pathway to GLP- 
1/exendin-4, INS-1/832/13 cells were treated with cytokines in the absence or 
presence of exendin-4. Exendin-4 significantly reduced reporter activity in the 
presence of cytokines (Figure 3-5). Western blot analysis of caspase-3 (Figure 3- 
6) showed a time dependent increase in caspase-3 cleavage in response to 
cytokines, but no caspase-3 cleavage was observed in the presence of exendin- 
4. This result clearly demonstrates the strength of the imaging system as it can 
easily capture changes in caspase-3 activity after treatment with exendin-4 that 
are not apparent by Western blot analysis. Previous studies have shown by 
fluorometric assays that exendin-4 and GLP-1 decrease caspase-3 activity62. 
Tews et al62 reported a 30% reduction in caspase-3 activity after a 5 h exposure 
to exendin-4 and a 22 h cytokine exposure62. The magnitude of the reduction in 
caspase-3 activity by exendin-4 in their study is similar to my observations, 
further solidifying the validity of this method. Imaging and fluorometric caspase-3 
assays demonstrate their strengths over Western blot analysis because their 
dependence on enzymatic activity is independent of antibody immunoreactivity 
and they are quantitative measures. This provides a high level of consistency in 
measurement and increased sensitivity to subtle changes ine caspase-3 activity.
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Both techniques are highly sensitive, but the advantage of our imaging technique 
over the fluorometric assay is the ability to repeatedly image the same population 
of cells and the ability to keep the cells intact. With this experiment I 
demonstrated the strength of the reporter because of its high sensitivity to 
changes in caspase-3 activity even in the presence of a known caspase-3 
inhibitor.
Since I was able to demonstrate that the caspase-3 reporter could detect the 
effects of exendin-4 on caspase-3 activity, I next investigated the time course of 
changes of other components of the intrinsic pathway of apoptosis. Caspase-9 
cleavage immediately precedes caspase-3 cleavage in the intrinsic pathway. 
However, I did not find significant changes with respect to time in the generation 
cleaved caspase-9, even after a 12 h cytokine exposure (Figure 3-7). This result 
is in contrast to Grunnet et al’s51 study in 2009 that reported a significant 
cleavage of caspase-9 after 12 h and 24 h of cytokine exposure in parental INS-1 
cells and isolated islets 51. Both these cell populations, as previously discussed 
are heterogeneous cell populations and could have an effect on the observed 
differences in response. In the presence of exendin-4 neither cleaved nor full 
caspase-9 were observed. This result is consistent with the effects that exendin- 
4/GLP-1 has on reducing caspase-9 activity and expression26 63.
The protein BAD is also a component of the intrinsic pathway that acts upstream 
of caspase-3 (Figure 1-1). It acts as a switch between apoptosis and survival 
based on its phosphorylation state. Dephosphorylation of BAD precedes changes
in mitochondrial permeability, and is essential for the formation of the 
mitochondrial pore that results in the release of cytochome c into the cytosol. I 
found no significant changes in total BAD protein in response to cytokine 
treatment. Exendin-4 had no significant effect on total BAD expression (Figure 3- 
8). An examination of the phosphorylation state of BAD would have yielded 
important information with respect to the mechanism of exendin-4/GLP-1 
regulation of apoptosis in [3-cells. Three phosphorylation sites have been 
identified on BAD, Serine (Ser) 112, Ser136 and Ser155. Each of these sites is 
preferentially phosphorylated by a specifc kinase. Seri 55 is preferentially 
phosphorylated by Protein Kinase A (PKA), Ser136 by PKB/Akt and Seri 12 by 
MAP Kinase Activating Protein-Kinase 164. Exendin-4/GLP-1 has been shown to 
induce BAD phosphorylation at Ser13651 and Seri 1265. It is likely that GLP- 
1/exendin-4 causes phosphorylation at Ser155 since they have been shown to 
initiate insulin secretion in a cAMP/PKA dependent manner66,67.The failure to 
detect changes in the proteins upstream of caspase-3 in the intrinsic pathway by 
Western blot, or changes in caspase-3 cleavage after preincubation with 
exendin-4 demonstrates the limits of sensitivity of the antibodies in question. On 
top of the technical limitations, cell type differences may contribute to this 
response. Collier J et al56 compared INS-1/832/13 cells with a cytokine resistant 
clone (833/15) derived from the same parental population, and showed that the 
cytokine resistant clones are equally susceptible to chemical apoptosis inducing 
agents56. They also investigated the role of the proapoptotic Bcl-2 proteins Bax
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and Bak, which act downstream of BAD. They found that these proteins regulate 
chemically induced apoptosis in 832/13 cells; but silencing them does not protect 
832/13 cells from cytokine induced toxicity56. Previous work from the same group 
showed that over expression of the anti apoptotic protein, Bcl-2, did not confer 
protection against cytokine induced apoptosis68.
I next examined the effects of cytokines on events downstream of caspase-3 
activation. Poly(ADP)-ribose polymerase, or PARP, is a nuclear substrate of 
caspase-3. Using immunocytochemistry (ICC), I examined nuclear localization of 
cleaved PARP in the presence of cytokines with or without exendin-4. 
Unexpectedly, the ICC results showed high basal levels of cleaved PARP which 
then decreased by 4 h. The role of full length PARP is to repair DNA damage, a 
process that depletes cellular NAD+69. Cleavage of PARP slows down the 
depletion of NAD+, effectively reducing cell metabolism and leaving an energy 
reserve for apoptosis. It was shown by Burkart et al70 that PARP'/_ and PARP+/' 
mice are resistant to P-cell destruction by STZ. They showed that STZ treatment 
does not deplete NAD+ content in PARP'/_ or PARP+/' islets and the PARP'/_ islets 
are equally as susceptible to DNA fragmentation as the PARP+/+ islets70. This 
result in conjunction with the findings of Boulares et a l14 that caspase-3 resistant 
PARP mutants are more susceptible to cell death, shows that PARP cleavage 
may not necessarily be a hallmark of cell death but rather a marker of NAD+ 
depletion. Studies have shown that PARP is ubiquitously cleaved by caspase-3, 
but also that it is dispensable for apoptosis. Caspase-7 has been shown to
cleave PARP in a cell free system in the absence of caspase-371. With this 
redundancy between caspase-3 and caspase-7 with respect to PARP, it is 
possible that caspase-7 may be responsible for the high levels of basal cleaved 
PARP. Overall our experiments show a protection from apoptosis at the level of 
the post translational cleavage of caspase-3, and at the level of caspase-9 
expression.
4.4 Cytokines Induce Intrinsic Apoptosis
Apoptosis induced by the combination of IL-ip, IFN-y and TNF-a likely occurs via 
activation of both the intrinsic and extrinsic pathways. Using our caspase-3 
reporter, I was able to show that the peak of caspase-3 activity is a result largely 
of the actions of IL-1 (3 and IFN-y, and therefore of the intrinsic pathway of 
apoptosis. It has recently been shown that IL-1 (3 and IFN-y induce apoptosis 
through the intrinsic pathway in 3-cells51. TNF-a has not been shown to cause 
apoptosis in P-cells on its own. The transcriptional and splicing networks of P- 
cells that are regulated by IL-1 p and TNF-a in combination with IFN-y, have been 
elucidated by a recent microarray study72. This study found that IL-13 and TNF-a 
have similar effects with respect to genes that regulate inflammation and cause a 
decrease in the expression of incretin hormone receptors including the GLP-1 
receptor72. In the current literature, IFN-y enhances the actions of IL-1 p and TNF- 
a. Suk. K et al9 showed that IFN-y and TNF-a are equally effective at reducing 
cell viability as IL-1 p and IFN-y and that this combination induces significant 
caspase-3 and 8 like activity in MIN6N8 cells9. My results in examining the
6 6
effects of cytokines on mitochondrial membrane permeability suggest incomplete 
membrane uncoupling. The mitochondrial permeability images illustrate an 
important point that echoe findings from Bossy-Wetzel, E. et al73, that cytokines 
do not cause complete uncoupling of the mitochondrial membrane73. More 
specifically it was found that cytochrome c release from the mitochondrial 
intermembrane space occurrs independently of mitochondrial membrane 
depolarization73. A similar result was found by Chang I et al74 with IFN-y + TNF-a 
treatment, where they showed increases in cytosolic cytochrome c, but no 
corresponding change in mitochondrial permeability before 72 h74. Chang74 and 
Suk’s9 results with IFN-y and TNF-a synergism illustrate a new avenue that could 
be further studied with our imaging system and technique, as both studies 
demonstrated cleavage of caspase-3 after 36 h and 24 h of IFN-y and TNF-a 
treatment respectively. The notion of IFN-y and TNF-a synergism is worth 
exploring further with our imaging system as it is more readily quantifiable than 
traditional biochemical techniques. A direct quantitative comparison between 
these two combinations and any other combination of cytokines could easily be 
made within hours of cytokine treatment. With this imaging system we could 
determine whether IFN-y/TNF-a synergism plays a significant role in the early 
induction of caspase-3 activity.
4.5 Future Directions
One of the more interesting results from my work is the potential of the caspase- 
3-luciferase construct to image IFN-y/TNF-a synergism. In order to follow up
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these results, I could investigate caspase-3 activation with TNF-a in the presence 
of either IFN-y or IL-113. I would expect to find greater levels of caspase-3 activity 
with TNF-a/IFN-y than with TNF-a/IL-ip because of IFN-y’s ability to inhibit the 
cells ER stress defense mechanisms8. From those results I would conclude that 
IFN-y is essential to the initiation of cytokine induced (3-cell apoptosis.
I could also explore the effects of other inducers of apoptosis in (3-cells, such as 
STZ, high glucose and high fatty acids, on caspase-3 activity. I would 
characterize the response of the caspase-3 reporter to STZ, high glucose and 
fatty acids by treating cells with doses known to cause apoptosis, and image 
reporter activity. After having established a time for maximal caspase-3 activity I 
would explore the effects of glucose and fatty acids together. I would expect 
glucose and fatty acids to induce caspase-3 reporter activity after prolonged 
exposure separately and that the magnitude of the activation would not differ. 
When cells are incubated with high glucose and fatty acids together I would 
expect a reduction in the exposure time required to induce caspase-3 reporter 
activity. From those results I could conclude that the combination of high free 
fatty acids and hyperglycemia accelerates (3-cell apoptosis and contributes 
significantly to T2DM pathology.
Going beyond the cellular response, a transgenic mouse expressing the 
ANLucBCLuc reporter in the (3-cells could be generated and used to explore islet 
transplant apoptosis and, additionally, in vivo detection of endogenous islet 
apoptosis under various models of diabetes pathology. If a transgenic mouse
6 8
were to be made we could make a quick assessment of islet health after isolation 
and transplant the islets into diabetic mice. Following transplantation islet health 
can be monitored by imaging, and if the reporter indicates poor islet health, 
intervention that improves islet survival can be applied. These experiments would 
also provide valuable information regarding when islets are most susceptible to 
cell death during the isolation and transplantation. I believe this reporter construct 
would be useful in monitoring T1DM and T2DM pathology in vivo. In order to 
investigate T 1 DM pathology in vivo, a well established model of diabetes would 
be required. The STZ model could be applied to the transgenic mouse and 
imaging would be carried out before, immediately after, and daily or weekly until 
signs of overt diabetes are apparent. This would yield important information with 
respect to the nature of islet loss under the STZ model. Once this model is well 
understood, the same techniques could be applied to spontaneous models of 
T1DM and T2DM.
5 Conclusions
The objectives of this thesis were to demonstrate the efficacy of in vivo imaging 
of caspase-3 in a type 1 diabetes cell model, and to elucidate the mechanism of 
caspase-3 activation in the early stages of apoptosis. With respect to imaging, I 
was successful in both objectives, as I was able to quantitatively assess the level 
of caspase-3 activity in response to pro inflammatory cytokines, and found that 
the caspase-3 response is transient in INS-1 /832/13 cells. I was also able to
69
demonstrate that the intrinsic pathway activates caspase-3 early on, although 
details of the mechanism remain unclear.
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